Extraction–thermal lens quantification of cobalt with Nitroso-R-Salt in two-phase aqueous systems with water-soluble polymer polyethylene glycol

A novel method is proposed for the extraction-thermal lens quantification of cobalt with Nitroso-R-Salt based on the distribution of the colored complex in a two-phase aqueous system on the basis of poly-ethylene glycol (PEG) and an ammonium sulfate solution followed by its thermal lens detection in the extract. The limit of detection is 0.3 μM (20 ng/mL); the lower limit of the analytical range is 0.7 μM (40 ng/mL); the relative standard deviation for the concentrations 1–50 μM makes 1–3% (n = 6, P = 0.95). In the determination of cobalt by spectrophotometry under the same conditions, the detection limit is 10 μM (0.6 μg/mL) and the lower limit of the analytical range is 40 μM (2.5 μg/mL). The precision of thermal lens measurements in PEG solutions is higher in comparison to that in aqueous ones because of the weaker interference of convection in aqueous solutions of PEG.     

Sequential injection technique for determination of phenoxybenzamine hydrochloride and metoclopramide in pharmaceutical formulations

A sequential injection analysis (SIA) system is described for the determination of phenoxybenzamine hydrochloride and metoclopramide using spectrophotometer as detector. The method is based on the detection of an unstable red intermediate compound resulting from the reaction of phenoxybenzamine hydrochloride or metoclopramide with the diazotizating product of p-phenylenediamine with sodium nitrite in hydrochloric acid medium. The sampling frequency is 69 h⁻¹ and 75 h⁻¹ for phenoxybenzamine hydrochloride and metoclopramide, respectively. The linear range is 10–400 μg/mL for phenoxybenzamine hydrochloride with a detection limit of 0.081 μg/mL and 20–250 μg/mL for metoclopramide with a detection limit of 0.034 μg/mL. The RSD is 1.01 and 0.45% for phenoxybenzamine hydrochloride and metoclopramide, respectively. The proposed methods were used to determine phenoxybenzamine hydrochloride and metoclopramide in pharmaceuticals. The results are compared with those obtained by pharmacopoeia method. The article is published in the original.     

Method Development and Validation of a Rapid Determination of Ropinirole in Tablets by LC-UV

A reversed-phase high-performance liquid chromatographic (HPLC) method with UV detection was developed and validated for the determination of ropinirole (ROP) in tablets. The assay utilized UV detection at 250 nm and a Luna CN column (250 × 4.6 mm I.D, 5 μm). The mobile phases were comprised of acetonitrile: 10 mM nitric acid (pH 3.0) (75:25, v/v). Validation experiments were performed to demonstrate linearity, accuracy, precision, limit of quantitation (LOQ), limit of detection (LOD), and robustness. The method was linear over the concentration range of 0.5–10.0 μg mL⁻¹. The method showed good recoveries (99.75–100.20%) and the relative standard deviations of intra and inter-day assays were 0.38–1.69 and 0.45–1.95%, respectively. The method can be used for quality control assay of ropinirole.     

HPLC assay method for ceftibuten in plasma and its application to pharmacokinetic study

The purpose of this study was to validate a reliable analytical method for pharmacokinetic study of ceftibuten in human plasma by high performance liquid chromatography (HPLC) system with UV detection. Ceftizoxime was used as the internal standard. After plasma sample was precipitated with acetonitrile and dichloromethane, the supernatant was directly injected into the HPLC system. Separation was performed on a Capcell Pak C₁₈ UG120 column (4.6 mm × 250 mm, 5 μm particles) with a mobile phase of acetonitrile/50 mM ammonium acetate (5: 95, v/v) and UV detection at a wavelength of 262 nm. The intra- and inter-day precision expressed as the relative standard deviation was less than 15%. The lower limit of quantification was 0.5 hg/mL of ceftibuten using 0.5 mL of plasma. The calibration curve was linear in concentration range of 0.5–30 μg/mL (r ² = 0.9998). The mean accuracy was 96–102%. The coefficient of variation (precision) in the intra- and inter-day validation was 0.9–3.9 and 0.9–2.4%, respectively. The pharmacokinetics of ceftibuten was evaluated after a single oral administration of 400 mg to healthy volunteers. The AUC_{0–9 h}, c _max, T _max, and T _1/2 were 86.6 ± 12.7 μg h/mL, 18.4 ± 1.5 μg/mL, 2.63 ± 0.83 and 2.65 ± 0.41 h, respectively. The method was demonstrated to be highly reproducible and feasible for pharmacokinetic studies of ceftibuten in eight volunteers after oral administration (400 mg as ceftibuten).     

Spectrophotometric determination of piroxicam

The possibility of the spectrophotometric determination of piroxicam based on the extraction of its ion associate (IA) with the polymethine dye, 5-thiocyanate-1,3,3-trimethyl-2[(1E)-3-[(2E)-1,3,3-trime-thyl-1-H-indol-2-ilidine]-propenyl]-3H-indolium chloride. The maximal recovery of IA with toluene is achieved when pH of the aqueous phase is 8.0–12.0 and the concentration of the dye is (1.0–2.0) × 10⁻⁴. The molar absorption coefficient of IA is 8 × 10⁴, the detection limit of piroxicam is 0.49 μg/mL. A procedure has been developed for the extraction-spectrophotometric determination of piroxicam in the concentration range 1.0–20.0 μg/mL.     

Selective Determination of Sulfonamide Residues in Honey by SPE-RP-LC with UV Detection

Solid-phase extraction was used to isolate sulfacetamide, sulfathiazole, sulfapyridine, sulfamerazine, sulfamethoxypyridazine and sulfamethoxazole from honey. The optimized procedure used polymeric Abselut Nexus cartridges and the sulfonamides were separated, in the isocratic mode, on an Inertsil ODS-3 (250 × 4 mm I.D., 5 μm) column, using methanol-0.05 M acetate buffer (pH 3.6) (20:80 v/v) with 1% (v/v) of acetic acid, UV detection at 263 nm and a flow-rate of 1 mL min⁻¹. Caffeine was used as internal standard. Average recoveries of the analytes from spiked honey ranged from 80 to 117% and the detection limits based on a spiked honey extract were 20–25 μg kg⁻¹.     

Selective spectrophotometric determination of paracetamol with sodium nitroprusside in pharmaceutical and biological samples

A novel simple method to determine paracetamol with good selectivity has been established by using sodium nitroprusside as the chromogenic reagent. The experiment indicates that sodium nitroprusside can react with paracetamol in a basic solution to form a product with colored O-nitrosamines. The maximal absorption wavelength (λ_max) and the apparent molar absorption coefficient of the product are 700 nm and 3.4 × 10³ L/mol cm, respectively. A Good linear relationship is obtained between the absorbance and the concentration of paracetamol in a wide range of 0.19–96 μg/mL. The linear regression equation is A = 0.01695 + 0.02240C (μg/mL), with a correlation coefficient of 0.9993. The detection limit (3σ/κ) is 0.10 μg/mL, and the relative standard deviation (RSD) is 0.90% (n = 11). The parameters with regard to determination are optimized, and the reaction mechanism is discussed. The method has been successfully applied to the selective determination of paracetamol in pharmaceutical and biological samples.     

Sequential injection technique for the determination of chlorpromazine hydrochloride in pure form and pharmaceutical formulations

A simple, economical, and automated spectrophotometric method for the determination of chlorpromazine hydrochloride by sequential injection analysis using ammonium metavanadate as colorimetric reagent is proposed. The various chemical and physical conditions that affected the reaction have been thoroughly investigated. The calibration curve was linear within the range 10–100 μg/mL. The detection limit (S/N = 3) was 0.7 μg/mL and the limit of quantification (S/N = 10) was 2.3 μg/mL. The sampling frequency was 22 h⁻¹. The method has been used for the determination of chlorpromazine hydrochloride in pure form and pharmaceutical formulations. The t-test has revealed that there is no evidence of significant differences between the obtained results at the 95% confidence level. The method can be applied to the quantitative determination of chlorpromazine hydrochloride. It is also applicable in the quality control of chlorpromazine hydrochloride preparations. The text was submitted by the authors in English.     

Determination of (E)-3,5,4′-Trimethoxystilbene in Rat Plasma by LC with ESI-MS

(E)-3,5,4′-trimethoxystilbene (BTM-0512) is a resveratrol analog with a variety of pharmacological action, including anti-cancer properties, anti-allergic activity, estrogenic activity, antiangiogenic activity, and vascular-targeting activity against microtubule-destabilization. There is, however, no validated analytical method for quantification of (E)-3,5,4′-trimethoxystilbene in biological matrices, so pharmacokinetic data and suitable methods for determination of the compound in plasma are currently lacking. A rapid and sensitive liquid chromatographic–mass spectrometric method for determination of (E)-3,5,4′-trimethoxystilbene in rat plasma, using carbamazepine as internal standard, has been developed and validated. Plasma samples were treated with acetonitrile to precipitate proteins. Samples were then analyzed by HPLC on a 250mm × 4.6 mm i.d., 5-μm particle, C₁₈ column with methanol–water, 80:20 (v/v), containing 10 mm ammonium acetate and 0.2% formic acid (pH 3.0), as mobile phase, delivered at 0.85 mL min⁻¹. A single-quadrupole mass spectrometer with an electrospray interface operated in selected-ion monitoring mode was used to detect [M + H]⁺ ions at m/z 271.3 for (E)-3,5,4′-trimethoxystilbene and m/z 237.5 for the internal standard. (E)-3,5,4′-trimethoxystilbene and the internal standard eluted as sharp, symmetrical peaks with retention times of 8.9 and 4 min, respectively. Calibration plots for (E)-3,5,4′-trimethoxystilbene in rat plasma at concentrations ranging from 0.01 to 5.0 μg mL⁻¹ were highly linear. Intra-day and inter-day precision, as RSD, was <12.9%, and accuracy was in the range 94.8–104.7%. The limit of detection in plasma was 0.005 μg mL⁻¹. The method was successfully used to determine the concentration of (E)-3,5,4′-trimethoxystilbene after oral administration of 86 mg kg⁻¹ of the drug to Sprague–Dawley rats and can be used to investigate the pharmacokinetics of the compound.     

Determination of guaiphenesin and sodium benzoate in Liqufruta garlic cough medicine by high performance liquid chromatography

A new and simple isocratic high-performance liquid chromatographic method with ultraviolet detection is described for simultaneous determination of active guaiphenesin and preservative sodium benzoate in Liqufruta garlic cough medicine formulation. The chromatographic separation was achieved using a Zorbax CN; 150 mm × 4.6 mm and 5 μm particle size column employing acetonitrile and water (20: 80, v/v) containing 0.1% formic acid (pH 3.5 ± 0.05) as the mobile phase. The method was validated with respect to linearity, range, precision, accuracy, specificity, limit of detection and limit of quantitation. The both analytes were detected by UV-Vis detector at 245 nm. The method was linear over the concentration range of 0.2–0.8 mg/mL and 0.02–0.06 mg/mL for guaiphenesin and sodium benzoate, respectively. The limit of detection was found to be 0.14 μg/mL for GP and 0.06 μg/mL for SB and the quantification limit was 0.54 μg/mL for GP and 0.22 for SB. Accuracy, evaluated as recovery, was in the range of 97.8–100.0%. Intra-day precision and intermediate precision showed relative standard deviation <1% in each case.     

FIA determination of pyruvate in serum based on direct chemiluminescence oxidation

Chemiluminescence was observed by mixing acidic potassium permanganate solution with pyruvate in the presence of quinine. A new simplified method for pyruvate determination based on this phenomenon was established. The chemiluminescence intensity is a linear function of the concentration of pyruvate in the range of 2 × 10^–6 to 1 × 10^–3 g/mL with a detection limit of 0.8 μg/mL and a relative standard deviation of less than 2.3%. The method has been successfully used to determine pyruvate in serum. Received: 3 April 1998 / Revised: 20 July 1998 / Accepted: 17 September 1998     

Spectrophotometric determination of furosemide in pharmaceutical dosage forms using complex formation with Cu(II)

A simple, sensitive, and accurate spectrophotometric method has been developed for the assay of furosemide (FUR), which is based on the complexation of the drug with copper(II) at pH 3.2 using Mclivaine buffer solution to produce a green adduct. The latter has maximum absorbance at 790 nm and obeys Beer’s law within the concentration range 5–30 μg/mL. Regression analysis of the calibration data showed a good correlation coefficient (r = 0.9997) with minimum detection limit of 0.23 μg/mL. The proposed procedure has been successfully applied to the determination of this drug in tablets. In addition, the spectral data and stability constant for the mononuclear copper(II) complex of furosemide (CuFUR₂(MeOH)₂) are reported. The text was submitted by the author in English.     

Fluorescent determination of cardiolipin using 10-<Emphasis Type="Italic">N</Emphasis>-nonyl acridine orange

Cardiolipin (CL) plays an essential role as a marker for cell apoptosis. Quantitative detection of phospholipids (PLs) by UV absorbance is problematic due to the presence of few double bonds in the structure. Although 10-N-nonyl acridine orange (NAO) has been utilized for fluorescent visualization of liposomes and mitochondria through its interaction with CL, in this work, we have developed a specific fluorescent method for CL in solution using NAO. The interaction of sodium n-dodecyl sulfate (SDS), used to treat cells prior to lipid extraction, and other PLs found in cell membranes such as phosphatidic acid (PA), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylglycerol (PG), phosphatidiylserine (PS), and sphingomyelin (SM) with NAO is investigated. The fluorescence intensity of the 0.5 μM NAO signal is strongly quenched by SDS below 25% methanol in water but with a methanol content above 50%, no quenching of NAO by SDS is observed. No fluorescence quenching of NAO with a 50% methanol/50% water solvent by the previously mentioned PLs or 4–20 μM cholesterol with the exception of PG at above 8 μM is noted. Using this 50% methanol/50% water solvent, the fluorescence signal due to the NAO–CL interaction is quite stable from 3 to at least 15 min. With excitation and emission wavelengths set at 518 and 530 nm, respectively, 20 μM NAO provides an inverse linear fluorescence response at 0.2–10 μM CL with a correlation coefficient of 0.9929. The detection limit is 0.2 μM and the limit of quantification is 0.6 μM. Structurally analogous acridine orange and phenosafranin dyes are less effective as fluorescent probes for CL. The CL in the whole cell and membrane samples is quantitatively determined by standard addition to range from 0.2 to 1.5 μM. The level of CL in cell membrane samples, previously subjected to staurosporine which initiates cell apoptosis, is increased but not significantly through use of the t-test.     

Utility of Certain σ and π-Acceptors for the Spectrophotometric Determination of Sildenafil Citrate (Viagra)

 The molecular interaction between sildenafil citrate as electron donor and each of iodine; 7,7,8,8-tetracyanoquinodimethane (TCNQ); 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ); tetracyanoethylene (TCNE); 2,4,7-trinitro-9-fluorenon (TNF); chloranilic acid (CLA); chloranil (CL) and bromanil (BL) as acceptors have been investigated spectrophotometrically. Different variables affecting the reaction were studied and optimized. Beer’s law was obeyed in a concentration limit of 10–260 μg/mL for sildenafil citrate. For more accurate analysis, Ringbom optimum concentration range was found to be between 20–240 μg/mL. The limits of detection and determination were calculated and found to be 1.5 and 5.2 μg/mL, respectively. The standard deviations were calculated for different concentrations of sildenafil citrate using various acceptors. A Job’s plot of the absorbance versus the molar ratio of the sildenafil citrate to each of acceptors under consideration indicated (1:1) ratio. The proposed methods were found to be rapid, accurate, precise and sensitive and could be applied for determination of sildenafil citrate in pharmaceutical dosage forms (Viagra) without interferences from common additives encountered. Received August 30, 2000. Revision January 5, 2001.     

A novel method for the determination of tiopronin by using potassium ferricyanide as spectroscopic probe reagent in pharmaceutical and urine samples

In this paper, a novel method has been established to determine tiopronin using potassium ferricyanide as spectroscopic probe reagent. It has been demonstrated that Fe(III) is reduced to Fe(II) by tiopronin, and the in situ formed Fe(II) reacts with potassium ferricyanide to form soluble Prussian blue. Beer’s law is obeyed in the range of tiopronin concentration of 0.040–9.00 μg/mL at the maximal absorption wavelength of 735 nm. The linear regression equation is A = 0.0153 + 0.1605c (μg/mL) with a correlation coefficient of 0.9997 and the apparent molar absorption coefficient of 2.6 × 10⁴ L/mol cm. The detection limit is 0.030 μg/mL and RSD is 1.3%. The parameters with regard to determination have been optimized and the reaction mechanism has been discussed. This method has been successfully applied to determine tiopronin in pharmaceutical and urine samples with satisfactory results.     

Flow injection spectrophotometric determination of ultra trace amounts of oxalic acid

A new simple, sensitive and rapid catalytic-spectrophotometric method for the determination of oxalic acid has been described based on its catalytic effect on the redox reaction between dichromate and Brilliant cresyl blue in acidic media by means of a flow injection analysis method. The color change of Brilliant cresyl blue due to its oxidation was monitored spectrophotometrically at 625 nm. The calibration graph was linear in the range of 0.020–4.70 μg/mL oxalic acid with a limit of detection 0.005 μg/mL of oxalic acid. The relative standard deviation for ten replicate measurements of 0.020 μg/mL and 0.900 μg/mL was 2.2% and 1.7%, respectively. No serious interference was identified. Oxalic acid was determined in wastewater and in spinach by the proposed method with satisfactory results. Received: 28 October 1999 / Revised: 13 January 2000 / /Accepted: 20 January 2000     

Chemiluminescence flow system for the determination of Fe(II) and Fe(III) in water

A novel chemiluminescence (CL) flow system has been developed for the sequential determination of Fe(II) and Fe(III) in water. Fe(II) was detected by its catalytic effect on the CL reaction between luminol immobilized on an anion exchange resin column and dissolved oxygen; Fe(III) was determined by difference measurement after on-line conversion to Fe(II) in a reducing mini-column packed with Cu plated Zn granules. For both ions, the calibration graph was linear in the range 1 × 10^–9 to 1 × 10^–6 g/mL, and the detection limit was 4 × 10^–10 g/mL. A complete analysis could be performed in 1.5 min with a relative standard deviation of less than 5%. The system could be reused for over 200 times and has been applied successfully to the determination of Fe(II) and Fe(III) in natural water samples. Received: 13 March 1997 / Revised: 3 June 1997 / Accepted: 6 June 1997     

Determination of Trihalomethanes in Drinking Water by Dispersive Liquid–Liquid Microextraction then Gas Chromatography with Electron-Capture Detection

Dispersive liquid–liquid microextraction (DLLME) has been used for preconcentration of trihalomethanes (THMs) in drinking water. In DLLME an appropriate mixture of an extraction solvent (20.0 μL carbon disulfide) and a disperser solvent (0.50 mL acetone) was used to form a cloudy solution from a 5.00-mL aqueous sample containing the analytes. After phase separation by centrifugation the enriched analytes in the settled phase (6.5 ± 0.3 μL) were determined by gas chromatography with electron-capture detection (GC–ECD). Different experimental conditions, for example type and volume of extraction solvent, type and volume of disperser solvent, extraction time, and use of salt, were investigated. After optimization of the conditions the enrichment factor ranged from 116 to 355 and the limit of detection from 0.005 to 0.040 μg L⁻¹. The linear range was 0.01–50 μg L⁻¹ (more than three orders of magnitude). Relative standard deviations (RSDs) for 2.00 μg L⁻¹ THMs in water, with internal standard, were in the range 1.3–5.9% (n = 5); without internal standard they were in the range 3.7–8.6% (n = 5). The method was successfully used for extraction and determination of THMs in drinking water. The results showed that total concentrations of THMs in drinking water from two areas of Tehran, Iran, were approximately 10.9 and 14.1 μg L⁻¹. Relative recoveries from samples of drinking water spiked at levels of 2.00 and 5.00 μg L⁻¹ were 95.0–107.8 and 92.2–100.9%, respectively. Comparison of this method with other methods indicates DLLME is a very simple and rapid (less than 2 min) method which requires a small volume of sample (5 mL).     

Simultaneous quantification of cefpirome and cetirizine or levocetirizine in pharmaceutical formulations and human plasma by RP-HPLC

A rapid and sensitive high-performance liquid chromatographic (HPLC) assay for the simultaneous determination and quantification of cefpirome and cetirizine or cefpirome and levocetirizine in pharmaceutical formulations and human plasma without changing the chromatographic conditions is described. Chromatographic separations were performed on a prepacked Nucleosil 120, C₁₈ (5 μm, 12.5 ± 0.46 mm) column using CH₃CN: H₂O (75: 25, v/v) as a mobile phase at a flow rate of 1 mL/min while UV detection was performed at 232 nm for monitoring the effluent. A number of other brands of C₁₈ columns were also employed which had a significant effect on the separation. The method has been validated over the concentration range of 0.5–50 μg/mL (r ₂ > 0.999). The limit of detection (LOD) and quantification (LOQ) for cefpirome and levocetirzine in pharmaceutical formulations and serum were in the range 0.24–1.31 μg/mL. Analytical recovery from human plasma was >98%, and the within and between-day relative standard deviation was <3.1%. The small sample volume and simplicity of preparation make this method suitable for use in pharmaceutical industries, drug research centers, clinical laboratories, and forensic medical centers. The text was submitted by the authors in English.     

Determination of cyanide in blood by electrospray ionization tandem mass spectrometry after direct injection of dicyanogold

An electrospray ionization tandem mass spectrometric (ESI-MS-MS) method has been developed for the determination of cyanide (CN^–) in blood. Five microliters of blood was hemolyzed with 50 μL of water, then 5 μL of 1 M tetramethylammonium hydroxide solution was added to raise the pH of the hemolysate and to liberate CN^– from methemoglobin. CN^– was then reacted with NaAuCl₄ to produce dicyanogold, Au(CN)₂^–, that was extracted with 75 μL of methyl isobutyl ketone. Ten microliters of the extract was injected directly into an ESI-MS-MS instrument and quantification of CN^– was performed by selected reaction monitoring of the product ion CN^– at m/z 26, derived from the precursor ion Au(CN)₂^– at m/z 249. CN^– could be measured in the quantification range of 2.60 to 260 μg/L with the limit of detection at 0.56 μg/L in blood. This method was applied to the analysis of clinical samples and the concentrations of CN^– in the blood were as follows: 7.13 ± 2.41 μg/L for six healthy non-smokers, 3.08 ± 1.12 μg/L for six CO gas victims, 730 ± 867 μg for 21 house fire victims, and 3,030 ± 97 μg/L for a victim who ingested NaCN. The increase of CN^– in the blood of a victim who ingested NaN₃ was confirmed using MS-MS for the first time, and the concentrations of CN^– in the blood, gastric content and urine were 78.5 ± 5.5, 11.8 ± 0.5, and 11.4 ± 0.8 μg/L, respectively.